PHARMACEUTICAL EXECUTIVE NEWSLETTER

In this ISSUE

Shining a Light on Supply Chain Visibility

Organizational Design and Talent Strategy in a Changing Pharma Landscape

What's Behind the Clinical Innovation Gap?

Top Story

Drug Marketing and Advertising Under Fire

FDA is moving slowly in liberalizing off-label communications amid outrage over opioid promotion. Jill Wechsler reports
… /Read more/

Deloitte's 2018 Life Sciences Accounting & Financial Reporting Update
How can life sciences companies keep pace with emerging accounting and financial reporting challenges? Learn about new accounting standards for revenue recognition, leases, and definition of a business and existing rules for R&D, acquisitions and divestitures, income taxes and more. Our ninth annual report also includes interpretive guidance to help you address these challenges.

Download now.

Value

Opening Up ICER's Black Box

Leela Barham reviews the Institute for Clinical Effectiveness Review's announced pilot program allowing manufacturers to scrutinize executable versions of draft cost-effectiveness models
… /Read more/

HCP Multichannel Marketing – What Does Great Look Like?
Live Webcast: Wednesday, April 11 at 1pm EDT

Calendar

/ May 10–11: Pharma Marketing Summit /

Palm Beach, FL

/ May 23: Artificial Intelligence for Drug Discovery /

Cambridge, MA

/ June 5–7: Pharmaceutical Compliance Congress Canada /

Toronto, Canada

/ June 13–14: Connected Devices in Life Sciences /

Boston, MA

/ June 14: GTN Bootcamp for Bioscience Companies /

San Francisco, CA

/ June 19–20: Rare Disease Innovation Summit /

Boston, MA

/ June 21–22: Disruptive Downstream Technologies /

San Diego, CA

/ August 7–8: Bio/Pharma Compliance Congress on Non-Promotional Activities /

Philadelphia, PA

/ October 15–17: 28^th Annual Sharing Conference: Compliance /

National Harbor, MD

Call for Nominations

Pharm Exec's Emerging Pharma Leaders 2018

Pharm Exec is preparing its annual spotlight on the industry's new generation of pharma leaders. Nominate a colleague or yourself as a 2018 Emerging Pharma Leader
… /Read more/

CRO Consolidation: A Sinister Threat or Windfall for Pharma?
On Demand

Learn more

Global

European Pharma: Plus ça change…

Looking back at the agenda of a 1985 EFPIA conference, Reflector sees that, three decades on, the European drug industry is still seeking a pill for its own ills
… /Read more/

Global

ANDA Approvals Boost Chinese Pharma's Global Ambitions

Jin Zhang looks at the Chinese pharma companies that received FDA ANDA approvals in 2017 and discusses how the country's industry is poised for further breakthrough
… /Read more/

Using Artificial Intelligence to Drive Innovation in the Life Sciences
On Demand

Learn more

Audio

The Pharm Exec Podcast:
Episode 5

In this episode of Pharm Exec's new podcast series, the editors talk with William Soliman of the Accreditation Council for Medical Affairs (ACMA)
… /Click here to listen/

Industry update

//Astellas Pharma's President and Chief Executive Officer Kenji Yasukawa announced the appointment of Percival Barretto-Ko to President, Americas Operations, for Astellas US LLC (Northbrook, IL). // Abeona Therapeutics (New York, NY and Cleveland, OH) appointed Carsten Thiel, Ph.D., as Chief Executive Officer. // PMV Pharmaceuticals (Cranbury, NJ) appointed Dr. Salim Yazji as Chief Medical Officer. // OncoMed Pharmaceuticals (Redwood City, CA) announced the appointment of Dr. John Lewicki as President and Chief Executive Officer. Dr. Lewicki was also appointed to the company's Board of Directors. //

advertise with us / print subscribe / digital subscribe / visit pharmexec.com